Why Intuitive Surgical Stock Is In Focus Now

Intuitive Surgical (ISRG) has drawn fresh attention after its board overhauled the company bylaws, tightened shareholder nomination rules, and adjusted voting standards for corporate actions, prompting investors to reassess governance and stock implications.

Intuitive Surgical shares trade at US$352.97, with the 7 day share price return of 6.31% standing in contrast to a 30 day share price decline of 11.24% and a year to date share price decline of 37.19%. The 3 year total shareholder return of 13.39% suggests longer term holders have had a different experience. Recent governance changes, the ongoing recall of certain da Vinci SP drapes, and a fresh shelf registration sit in the background as investors reassess both growth potential and risk around the stock.

If this governance reset has you rethinking your exposure to surgical robotics, it could be a good moment to scan the wider field of healthcare automation through the 41 healthcare AI stocks

The recent rebound in Intuitive Surgical stock sits between two stories. One points to a resilient surgical robotics business. The other looks like sentiment snapping back after a steep pullback. Which version does the current valuation reflect?

Most Popular Narrative: 44% Undervalued

The most followed narrative on Intuitive Surgical pegs fair value at $630.48, well above the last close at $352.97. That gap sets up a very different take on the recent selloff.

I have followed ISRG since 2003 when it was brought to the investing club I had just joined. I tried to analyze ISRG with the BetterInvesting SSG methodology that I had been introduced to and I could not get it in the buy zone. Wiser heads in the club prevailed and we started a position at around $48 a share and continued to add to the position. In 2005 ISRG was trading at over $200 a share and I was getting nervous. I convinced the club to place a trailing stop on ISRG. The price continued to increase and reached $393 a share. Then ISRG stock price started to drop it got as low as $200 a share. Our trailing stop worked like a charm we were sold out of the club position at just above $360 a share. I tried to convince the club to reinvest in ISRG at $200 a share they decided not to, but I did. I describe it as riding the lightning.

Want to know what sits behind that punchy $630.48 fair value for Intuitive Surgical? The narrative leans heavily on double digit revenue and earnings growth and a premium future earnings multiple. Curious how those ingredients combine to produce such a large gap to today’s price? The full narrative spells out the numbers and the reasoning in detail.

Result: Fair Value of $630.48 (UNDERVALUED)

However, this Intuitive Surgical story could be challenged by any setback around product recalls or by stricter hospital capital budgets that weigh on system placements.

Another View On Intuitive Surgical Valuation

The most popular Intuitive Surgical narrative leans on a rich future earnings multiple and points to a fair value well above the current US$352.97 share price. The market today is using a P/E of 39.7x, which is higher than the US Medical Equipment industry average and peer average of 28.8x, and above the fair ratio of 34.4x. That gap suggests investors are already paying a premium for this growth profile, so it is worth considering how comfortable you are with that extra valuation risk if expectations change.

Next Steps

If the mix of optimism and caution around Intuitive Surgical leaves you uncertain, review the details and form your own stance by checking the 3 key rewards

Looking for more investment ideas beyond Intuitive Surgical?

If Intuitive Surgical has you thinking more broadly about your portfolio, this can be a time to explore other opportunities that could round out your exposure.

• Target reliable income by checking out companies that make the cut in our 8 dividend fortresses.
• Spot compelling value opportunities early by reviewing the screener containing 20 high quality undiscovered gems before they appear on everyone else's radar.
• Prioritize capital preservation and focus on steadier outcomes by looking at companies highlighted in the 89 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.